PT1206256E - Terapia de combinacao utilizando pentafluorobenzenosulfonamida e compostos de platina - Google Patents
Terapia de combinacao utilizando pentafluorobenzenosulfonamida e compostos de platinaInfo
- Publication number
- PT1206256E PT1206256E PT00953755T PT00953755T PT1206256E PT 1206256 E PT1206256 E PT 1206256E PT 00953755 T PT00953755 T PT 00953755T PT 00953755 T PT00953755 T PT 00953755T PT 1206256 E PT1206256 E PT 1206256E
- Authority
- PT
- Portugal
- Prior art keywords
- pentafluorobenzenosulfonamide
- combination therapy
- platinum compounds
- pentafluorobenzenesulfonamide
- cisplatin
- Prior art date
Links
- 238000002648 combination therapy Methods 0.000 title abstract 2
- 229940045985 antineoplastic platinum compound Drugs 0.000 title 1
- 150000003058 platinum compounds Chemical class 0.000 title 1
- ZWVYQZBCSXCUOO-UHFFFAOYSA-N 2,3,4,5,6-pentafluorobenzenesulfonamide Chemical compound NS(=O)(=O)C1=C(F)C(F)=C(F)C(F)=C1F ZWVYQZBCSXCUOO-UHFFFAOYSA-N 0.000 abstract 1
- 230000000118 anti-neoplastic effect Effects 0.000 abstract 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 abstract 1
- 229960004316 cisplatin Drugs 0.000 abstract 1
- 229910052697 platinum Inorganic materials 0.000 abstract 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 1
- -1 platinum coordination complex Chemical class 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Weting (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14643699P | 1999-07-29 | 1999-07-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1206256E true PT1206256E (pt) | 2005-09-30 |
Family
ID=22517356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00953755T PT1206256E (pt) | 1999-07-29 | 2000-07-27 | Terapia de combinacao utilizando pentafluorobenzenosulfonamida e compostos de platina |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6355628B1 (https=) |
| EP (1) | EP1206256B8 (https=) |
| JP (1) | JP2003505513A (https=) |
| KR (1) | KR100685059B1 (https=) |
| CN (1) | CN1181819C (https=) |
| AT (1) | ATE294574T1 (https=) |
| AU (1) | AU775305B2 (https=) |
| CA (1) | CA2380078C (https=) |
| DE (1) | DE60019937T2 (https=) |
| DK (1) | DK1206256T3 (https=) |
| ES (1) | ES2241639T3 (https=) |
| IL (2) | IL147890A0 (https=) |
| PT (1) | PT1206256E (https=) |
| RU (1) | RU2268054C2 (https=) |
| WO (1) | WO2001008693A2 (https=) |
| ZA (1) | ZA200200889B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT896533E (pt) * | 1996-02-22 | 2004-02-27 | Tularik Inc | Pentafluorobenzenosulfonamidas e analogos |
| PT939627E (pt) * | 1996-07-19 | 2004-02-27 | Tularik Inc | Pentafluorobenzenossulfonamidas e analogos |
| DE69908156T2 (de) * | 1998-09-23 | 2003-12-24 | Tularik, Inc. | Arylsulfonanilid-harnstoffe |
| WO2002039958A2 (en) | 2000-11-03 | 2002-05-23 | Tularik Inc. | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents |
| US20050250854A1 (en) * | 2000-11-03 | 2005-11-10 | Amgen Inc. | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents |
| FR2834641B1 (fr) * | 2002-01-14 | 2005-04-22 | Ct Regional De Lutte Contre Le | Protection de la neurotoxicite de l'oxaliplatine par administration de calcium et de magnesium |
| WO2005051303A2 (en) * | 2003-11-19 | 2005-06-09 | Lixin Zhang | Screening for synergistic compounds |
| US10238831B2 (en) | 2013-09-08 | 2019-03-26 | Qool Therapeutics, Inc. | Temperature measurement and feedback for therapeutic hypothermia |
| EP3261593B1 (en) | 2015-02-23 | 2021-11-03 | Qool Therapeutics, Inc. | Systems and methods for endotracheal delivery of frozen particles |
| US11186549B2 (en) | 2017-08-29 | 2021-11-30 | Rutgers, The State University Of New Jersey | Therapeutic indazoles |
| CA3113532A1 (en) * | 2017-09-21 | 2019-03-28 | Dalriada Therapeutics Inc. | Pentafluorophenyl sulfonamide compounds, compositions and uses thereof |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1955207A (en) | 1931-09-16 | 1934-04-17 | Ig Farbenindustrie Ag | Mothproofing agent |
| US2402623A (en) | 1943-06-24 | 1946-06-25 | Rohm & Haas | Nu-nitroaryl haloarylsulphonamides |
| CH362688A (de) | 1957-09-10 | 1962-06-30 | Geigy Ag J R | Verfahren zur Herstellung von neuen Arylsulfonarylamiden |
| GB1242057A (en) | 1968-07-04 | 1971-08-11 | Ici Ltd | Derivatives of 4-hydroxytetrafluoropyridine and the use thereof as plant growth regulators |
| NL174644C (nl) | 1970-04-13 | 1984-07-16 | Minnesota Mining & Mfg | Werkwijze ter bereiding van een herbicide verbinding; tevens werkwijze voor de bereiding van een preparaat met herbicide werking. |
| US4225529A (en) * | 1977-10-19 | 1980-09-30 | Johnson, Matthey & Co., Limited | Compositions containing platinum |
| DE3623184A1 (de) | 1986-07-10 | 1988-01-14 | Kali Chemie Ag | Verfahren zur herstellung von n-fluorsulfonamiden |
| US4883914A (en) | 1987-08-17 | 1989-11-28 | American Cyanamid Company | Benzenesulfonyl carboxamide compounds useful as herbicidal agents |
| DE3804990A1 (de) | 1988-02-18 | 1989-08-31 | Basf Ag | Herbizid wirksame, heterocyclisch substituierte sulfonamide |
| FR2645537B1 (fr) | 1989-04-05 | 1994-03-04 | Fabre Medicament Pierre | Nouveaux sulfonamides derives d'acides benzocycliques ou benzoheterocycliques, leur preparation et leur application en therapeutique |
| FR2665440B1 (fr) | 1990-07-31 | 1994-02-04 | Lipha | Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant. |
| US5189211A (en) | 1990-08-01 | 1993-02-23 | Taisho Pharmaceutical Co., Ltd. | Sulfonamide derivatives |
| DE69129611T2 (de) | 1990-08-20 | 1998-12-17 | Eisai Co., Ltd., Tokio/Tokyo | Sulfonamid-Derivate |
| RU2088288C1 (ru) * | 1993-07-29 | 1997-08-27 | Московский областной научно-исследовательский клинический институт | Способ лечения больных местнораспространенными формами рака |
| RU2098096C1 (ru) * | 1993-10-11 | 1997-12-10 | Московский научно-исследовательский онкологический институт им.П.А.Герцена | Средства, подавляющие рост раковых клеток |
| WO1996040629A1 (en) | 1995-06-07 | 1996-12-19 | Sugen, Inc. | Tyrphostin-like compounds for the treatment of cell proliferative disorders or cell differentiation disorders |
| PT896533E (pt) | 1996-02-22 | 2004-02-27 | Tularik Inc | Pentafluorobenzenosulfonamidas e analogos |
| PT939627E (pt) * | 1996-07-19 | 2004-02-27 | Tularik Inc | Pentafluorobenzenossulfonamidas e analogos |
| DE69729946T2 (de) * | 1996-10-15 | 2005-01-20 | G.D. Searle Llc | Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia |
| BR9713522A (pt) * | 1996-11-19 | 2000-03-21 | Searle & Co | Método de uso de inibidores da cicloxigenase-2 como agentes antiangiogênicos. |
| US5773236A (en) | 1997-04-25 | 1998-06-30 | Molecule Probes, Inc. | Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules |
| WO1999067258A1 (en) * | 1998-06-25 | 1999-12-29 | Tularik Inc. | Arylsulfonanilide phosphates |
| DE69908156T2 (de) * | 1998-09-23 | 2003-12-24 | Tularik, Inc. | Arylsulfonanilid-harnstoffe |
| AU2190700A (en) * | 1998-12-17 | 2000-07-03 | Tularik Inc. | Tubulin-binding agents |
| CO5170498A1 (es) * | 1999-05-28 | 2002-06-27 | Abbott Lab | Biaril sulfonamidas son utiles como inhibidores de proliferacion celular |
-
2000
- 2000-07-27 RU RU2002105374/15A patent/RU2268054C2/ru not_active IP Right Cessation
- 2000-07-27 DE DE60019937T patent/DE60019937T2/de not_active Expired - Fee Related
- 2000-07-27 US US09/627,041 patent/US6355628B1/en not_active Expired - Fee Related
- 2000-07-27 AU AU66152/00A patent/AU775305B2/en not_active Ceased
- 2000-07-27 KR KR1020027001254A patent/KR100685059B1/ko not_active Expired - Fee Related
- 2000-07-27 PT PT00953755T patent/PT1206256E/pt unknown
- 2000-07-27 CA CA002380078A patent/CA2380078C/en not_active Expired - Fee Related
- 2000-07-27 JP JP2001513423A patent/JP2003505513A/ja active Pending
- 2000-07-27 CN CNB00810977XA patent/CN1181819C/zh not_active Expired - Fee Related
- 2000-07-27 DK DK00953755T patent/DK1206256T3/da active
- 2000-07-27 IL IL14789000A patent/IL147890A0/xx active IP Right Grant
- 2000-07-27 WO PCT/US2000/020763 patent/WO2001008693A2/en not_active Ceased
- 2000-07-27 AT AT00953755T patent/ATE294574T1/de not_active IP Right Cessation
- 2000-07-27 ES ES00953755T patent/ES2241639T3/es not_active Expired - Lifetime
- 2000-07-27 EP EP00953755A patent/EP1206256B8/en not_active Expired - Lifetime
-
2002
- 2002-01-29 IL IL147890A patent/IL147890A/en not_active IP Right Cessation
- 2002-01-31 ZA ZA200200889A patent/ZA200200889B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2380078A1 (en) | 2001-02-08 |
| EP1206256B8 (en) | 2005-06-29 |
| EP1206256B1 (en) | 2005-05-04 |
| IL147890A0 (en) | 2002-08-14 |
| RU2002105374A (ru) | 2004-01-10 |
| KR20020050225A (ko) | 2002-06-26 |
| US6355628B1 (en) | 2002-03-12 |
| ZA200200889B (en) | 2003-03-26 |
| AU775305B2 (en) | 2004-07-29 |
| CA2380078C (en) | 2008-05-06 |
| IL147890A (en) | 2007-07-04 |
| ES2241639T3 (es) | 2005-11-01 |
| EP1206256A2 (en) | 2002-05-22 |
| DE60019937D1 (de) | 2005-06-09 |
| CN1367690A (zh) | 2002-09-04 |
| JP2003505513A (ja) | 2003-02-12 |
| AU6615200A (en) | 2001-02-19 |
| DK1206256T3 (da) | 2005-08-15 |
| RU2268054C2 (ru) | 2006-01-20 |
| WO2001008693A2 (en) | 2001-02-08 |
| ATE294574T1 (de) | 2005-05-15 |
| CN1181819C (zh) | 2004-12-29 |
| DE60019937T2 (de) | 2006-05-04 |
| WO2001008693A3 (en) | 2001-05-25 |
| KR100685059B1 (ko) | 2007-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU38801A (sh) | Azabicikloalkani kao modulatori ccr5 | |
| ATE434607T1 (de) | 1-(4-amino-cyclohexyl)-1,3-dihydro-2h- benzimidazole-2-on derivate und verwandte verbindungen als nociceptin analoge und orl1 liganden zur behandlung von schmerz | |
| DE60112974D1 (en) | Carbolinderivate | |
| PT1200412E (pt) | Agentes anti-proliferativos de imidazole | |
| BG108269A (en) | Pyrazolopyrimidines as therapeutic agents | |
| PT1244650E (pt) | Derivados arilaminas e sua aplicacao como agentes anti-telomerase | |
| DK1187632T3 (da) | Behandling med anti-ErbB2-antistoffer | |
| MXPA04005886A (es) | Derivados de azaindolilalquilamina como ligandos de 5-hidroxitirptamina-6. | |
| DE60216233D1 (en) | Carbolinderivate | |
| BR0116481A (pt) | Compostos de heterociclilalquilindol ou azaindol como ligandos de 5-hidroxitriptamina-6 | |
| PT1206256E (pt) | Terapia de combinacao utilizando pentafluorobenzenosulfonamida e compostos de platina | |
| ATE306281T1 (de) | Antivirales mittel in kombination mit strahlentherapie zur verwendung in der behandlung von krebs | |
| TR199901104T2 (xx) | Farmas�tik bile�ikler. | |
| ATE386742T1 (de) | Imidazonaphthyridine | |
| DE60115466D1 (de) | Wirkstoffvorläufer von imidazopyridin-derivaten | |
| BR9807883A (pt) | Compostos de tetraidropirido | |
| WO2002039958A3 (en) | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents | |
| ATE306283T1 (de) | Biotin-derivate und ihre konjugaten mit chelatierungsmitteln | |
| DE60010934D1 (de) | Medikamente geeignet zur Behandlung von proliferativen Erkrankungen | |
| DE69912477D1 (de) | Endokrintherapie für brustkrebs: kombinierte behandlung mit tamoxifen und alkyl-pcdfs | |
| TR200200987T2 (tr) | Kanser tedavisine yönelik,ornatılmış pirroller | |
| PL1814879T3 (pl) | Pochodne 4,7-dioksobenzotiazolo-2-karboksyamidu, ich wytwarzanie oraz ich zastosowania terapeutyczne | |
| PT1708693E (pt) | Composições farmacêuticas contendo complexos de platina com xantatos secundários e suas utilizações terapêuticas | |
| MXPA05002477A (es) | Asialo-interferones y el tratamiento de cancer de higado. |